| Leman SKL SA - Pazopanib Leman 400 mg, comprimés pélliculés | | 70608 | | 02 | | Pazopanib Leman 400 mg | | comprimés pélliculés | | L01EX03 | | Pazopanib | | 29.10.2026 | | |
| | Composition | | pazopanibum 400 mg ut pazopanibi hydrochloridum, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A, magnesii stearas, pellicule: E 171, hypromellosum, macrogolum 400, polysorbatum 80, E 172 (flavum), pro compresso obducto corresp. natrium 1.78 mg. | | Packungsbestandteile | | comprimés pélliculés | | | | Active Agent | Dose |
|---|
| Pazopanibum | 400 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | pellicule | | E 172 | | color. | | Hypromellosum | | | | Macrogol | 400 | | | Magnesii Stearas | | | | Polysorbatum 80 | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 30 | | | A | | Yes | | 005 | 60 | | | A | | Yes |
|
|